Algerian heart patients monitored on common blood thinner
Disease control
Completed
This study observed nearly 400 Algerian adults with atrial fibrillation who were prescribed the blood thinner Trombix® (rivaroxaban). The goal was to see how safe and effective the drug is in everyday use and how it affects patients' quality of life. Researchers tracked side effe…
Sponsor: Beker Laboratories • Aim: Disease control
Last updated Mar 13, 2026 15:05 UTC